Thanks to a great connection made at the High Museum Wine Auction over the years, we are coming back to Druid Hills Golf Club to host a TASTY WINE DINNER that kicks off a very special fundraising weekend at the club. Thursday night promises to be just the perfect way to launch into a great 3 days of fun, fun, and more fun!
Press On was formed by Erin and Stephen Chance after their three year-old son, Patrick, was diagnosed with stage IV neuroblastoma in June 2006. After his original diagnosis, Patrick endured three years of therapy, including multiple surgeries, 10 rounds of chemotherapy, the last of which was so strong he required an autologous stem cell transplant to survive, 12 rounds of radiation, 9 months of oral chemo, and 2 years of painful monoclonal antibody therapy. Despite this intense treatment, Patrick relapsed a mere two months after completing therapy.
After a valiant fight, Patrick passed away on his ninth birthday, January 9, 2012. In 2009, Press On’s mission grew to include a focus on acute myeloid leukemia (AML) when their dear friends Tara and Turner Simkins joined forces with Press On as a result of their son Brennan’s diagnosis with AML on the eve of his seventh birthday. It was a fitting partnership as AML is a common secondary cancer that neuroblastoma patients develop as a result of the harsh treatments required to battle neuroblastoma. Brennan received 3 chemotherapy cycles and an allogenic bone marrow transplant to achieve remission last summer. After relapsing multiple times, Brennan received a total of four stem cell transplants and is currently in remission. He is now fighting to find a cure with far fewer and riskier options available.
Childhood cancer is the number one disease killer of American children, killing more children than asthma, AIDS, muscular dystrophy and cystic fibrosis combined. The often-quoted cure rate for pediatric cancer is skewed by tremendous success in treating acute lymphoblastic leukemia, but the cure rates for stage IV neuroblastoma and AML are much lower. In fact, over 25% of children diagnosed with any type of cancer will die within five years and the overall cure rate for pediatric cancer has not improved in over a decade. This is simply unacceptable.
Press On’s goal is to achieve a greater cure rate for these cruel diseases while mitigating the potentially devastating side effects of current therapy, which can include secondary cancers, developmental delays, hearing loss, infertility, scoliosis, and others. To accomplish this goal, Press On provides grants to scientists conducting research into novel, targeted therapies for neuroblastoma and AML. Please
join us in the fight against childhood cancer.
Date: Thursday, May 16 2013
Price: SOLD OUT!